|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0805 USD | 0.00% |
|
0.00% | +29.84% |
International Stem Cell Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 0.214 million compared to USD 0.034 million a year ago. Basic loss per share from continuing operations was USD 0.03.
Diluted loss per share from continuing operations was USD 0.03.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.84% | 6L | |
| +34.14% | 5.11TCr | |
| -6.54% | 3.94TCr | |
| +34.92% | 3.85TCr | |
| +12.62% | 2.64TCr | |
| -12.11% | 2.62TCr | |
| -13.43% | 2.1TCr | |
| +43.73% | 1.4TCr | |
| +31.81% | 1.25TCr | |
| -4.54% | 1.16TCr |
INTERNATIONAL STEM CELL CORPORATION 
